Top Markets
Coin of the day
Vicapsys Life Sciences, Inc. Vicapsys Life Sciences, Inc.

Vicapsys Life Sciences, Inc.

VICP
Rankning i aktier #25708
Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive... Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive VICAPSYN product to market, guiding it through development and commercialization. This product's intended application is within the field of transplantation, specifically for various transplant therapies and associated stem-cell uses. Additionally, the company is advancing the development of VYBRIN, a compound based on CXCL12. VYBRIN is being investigated for multiple purposes: preventing the formation of post-surgical adhesions following abdominal operations, coating implantable medical devices and other implants to inhibit fibrosis, and promoting wound healing, with a particular emphasis on diabetic ulcers. The firm, originally incorporated in 1997, transitioned its name from Phage Therapeutics International, Inc. to Vicapsys Life Sciences, Inc. in September 2017. Its operations are headquartered in Suwanee, Georgia.
Aktiekurs
$1.45
Senast synkroniserad: 2026-08-19
Marknadsvärde
$46.94M
Förändring (1 dag)
0.00%
Förändring (1 år)
-18.08%
Land
US
Handel Vicapsys Life Sciences, Inc. (VICP)

Kategori

Aktiekurshistorik för Vicapsys Life Sciences, Inc. (VICP)
Högsta slutkurs: $1.45 den 2026-08-01

Lägsta slutkurs: $4.00K den 1998-02-01
Aktiekurshistorik för Vicapsys Life Sciences, Inc. från 1998 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) 1.38%
2025 -14.29%
2024 154.87%
2023 174.65%
2022 -50.00%
2021 33.33%
2020 0.00%
2019 -55.29%
2018 -6.80%
2017 -28.00%
2016 3,025.00%
2015 0.00%
2014 22.18%
2013 -67.67%
2012 -34.58%
2011 -94.15%
2010 -77.91%
2009 -6.88%
2008 -58.50%
2007 926.57%
2006 -33.53%
2005 -50.30%
2004 -58.93%
2003 -84.01%
2002 -89.45%
2001 44.98%
2000 27.56%
1999 44.30%
1998 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$539.14 35.65%
US
$1.04K 56.21%
NL
$119.71 -17.54%
AU
$761.87 8.65%
CH
$130.43 397.46%
US